You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 30 No. 1, January 1974 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (107)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Phenothiazine-Induced Decompensation

Theodore Van Putten, MD; Louis R. Mutalipassi, PhD; Michael D. Malkin, MD

Arch Gen Psychiatry. 1974;30(1):102-105.


Abstract

Adverse mental reactions to phenothiazines have been anecdotally reported. In a systematic study 80 patients with the diagnosis of schizophrenia received phenothiazines in conventional dosages. Nine patients experienced dramatic exacerbations of psychosis on phenothiazines with a piperazine side group—particularly fluphenazine enanthate.

These exacerbations of psychosis are associated with a subtle akathisia. Exacerbations of psychosis were promptly reversed by biperiden (Akineton)—an anticholinergic drug, given intramuscularly.

It is proposed that extrapyramidal involvement can have a prominent mental component which resembles an exacerbation of schizophrenia.



Author Affiliations

Los Angeles

From the Brentwood Veterans Administration Hospital and the UCLA School of Medicine, Los Angeles.


Footnotes

Accepted for publication June 19, 1973.

Reprint requests to Brentwood VA Hospital, Wilshire & Sawtelle Blvd, Ward 210-C, Los Angeles, CA 90072 (Dr. Van Putten).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Relationship of Akathisia With Suicidality and Depersonalization Among Patients With Schizophrenia
Cem Atbasoglu et al.
J. Neuropsychiatry Clin. Neurosi. 2001;13:336-341.
ABSTRACT | FULL TEXT  

Pharmacotherapy of Impaired Affect in Recovering Schizophrenic Patients
Hogarty et al.
Arch Gen Psychiatry 1995;52:29-41.
ABSTRACT  

A Controlled Dose Comparison of Haloperidol in Newly Admitted Schizophrenic Patients
Van Putten et al.
Arch Gen Psychiatry 1990;47:754-758.
ABSTRACT  

Norepinephrine in Acute Exacerbations of Chronic Schizophrenia: Negative Symptoms Revisited
van Kammen et al.
Arch Gen Psychiatry 1990;47:161-168.
ABSTRACT  

Akathisia and Head and Body Rocking in Schizophrenia
Lauterbach
JAMA 1987;257:2033-2034.
ABSTRACT  

Akathisia With Haloperidol and Thiothixene
Putten et al.
Arch Gen Psychiatry 1984;41:1036-1039.
ABSTRACT  

Haloperidol for Acute Schizophrenic Patients: An Evaluation of Three Oral Regimens
Donlon et al.
Arch Gen Psychiatry 1980;37:691-695.
 

Catatonic Reactions to High-Potency Neuroleptic Drugs
Gelenberg and Mandel
Arch Gen Psychiatry 1977;34:947-950.
ABSTRACT  

Variability in Schizophrenia: Reflection of a Regulatory Disease
van der Velde
Arch Gen Psychiatry 1976;33:489-496.
ABSTRACT  

The Long-Acting Phenothiazines
Groves and Mandel
Arch Gen Psychiatry 1975;32:893-900.
ABSTRACT  

Why Do Schizophrenic Patients Refuse to Take Their Drugs?
Van Putten
Arch Gen Psychiatry 1974;31:67-72.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.